# Program 1 Local Production Readiness Track

## Final Module Closure and Deferred Execution Hold

## 1. Final Status

- module status: `CLOSED`
- closure level: `DOCUMENTATION AND GOVERNANCE`
- runtime implementation: `NOT STARTED`
- runtime execution: `NOT AUTHORIZED`
- local evaluation: `NOT PERFORMED`
- runtime verification: `NOT PERFORMED`
- machine configuration: `NOT STARTED`
- machine approval: `NOT GRANTED`
- packaging: `NOT STARTED`
- installation: `NOT STARTED`
- deployment: `NOT STARTED`
- production use: `NOT AUTHORIZED`
- clinical use: `NOT AUTHORIZED`
- real-data access: `PROHIBITED`
- PHI handling: `PROHIBITED`
- PII handling: `PROHIBITED`
- UI: `NOT STARTED`
- No-UI Hold: `ACTIVE`
- network operation: `NOT AUTHORIZED`
- persistence: `PROHIBITED`
- export: `PROHIBITED`
- integrations: `PROHIBITED`
- clinical workflow: `PROHIBITED`
- patient messaging: `PROHIBITED`
- appointment mutation: `PROHIBITED`
- clinical writeback: `PROHIBITED`
- clinical task creation: `PROHIBITED`
- diagnosis: `NOT AUTHORIZED`
- treatment recommendation: `NOT AUTHORIZED`
- triage: `NOT AUTHORIZED`
- patient instruction: `NOT AUTHORIZED`
- go-live: `NOT AUTHORIZED`
- Phase I: `NOT STARTED`
- execution-review track: `NOT OPENED`
- final posture: `STOP AND HOLD`

## 2. Closure Purpose

This document closes the Local Production Readiness Track at the documentation and governance level.

The track produced boundary definitions, candidate definition, prohibited-path definitions, machine-security prerequisites, access and custody prerequisites, no-network operating requirements, UI readiness gate, real-data prerequisite gate, evidence-state model, preflight requirements, stop conditions, deviation-handling requirements, authorization packet structure, expiration rules, revocation rules, decision records, and hold records.

The track did not produce runtime implementation, runtime execution, local evaluation, machine configuration, machine approval, packaging, installation, runtime verification, UI, real-data access, PHI or PII handling, clinical workflow, integrations, deployment, production use, clinical use, or go-live.

`Documentation completion does not establish operational readiness.`

## 3. Phase Summary

### Phase A

Phase A defined the local-only production-readiness boundary, defined the future candidate concept, named the candidate `Local Clinician-Facing Synthetic Review Demo`, prohibited real data, prohibited PHI and PII, prohibited deployment and go-live, and did not implement or deploy anything.

### Phase B

Phase B defined local machine security requirements, access boundaries, custody requirements, and decommission expectations. It did not configure or approve a machine.

### Phase C

Phase C defined no-network requirements, zero external API expectations, zero database expectations, zero integration expectations, and zero telemetry expectations. It did not verify runtime behavior.

### Phase D

Phase D defined prerequisites before any UI track, defined prohibited UI controls, preserved No-UI Hold, and did not authorize or implement UI.

### Phase E

Phase E defined prerequisites before any possible future real-data read-only review, including privacy, legal, access, audit, and accountability requirements. It did not authorize real-data access, PHI, or PII.

### Phase F

Phase F consolidated readiness decisions, defined blockers, defined a hold record, and did not authorize implementation, deployment, or go-live.

### Phase G

Phase G defined local evaluation preflight requirements, evidence states, stop conditions, role and custody expectations, and evidence-record requirements. It did not perform preflight and did not execute the candidate.

### Phase H

Phase H defined the Local Synthetic Evaluation Authorization Packet, candidate identity requirements, role and accountability records, machine and custody declarations, synthetic-only declarations, no-network/no-persistence/no-export declarations, safety-label requirements, prohibited interpretations, stop conditions and deviations, authorization states, expiration, and revocation. It did not authorize execution, did not open Phase I, and did not open an execution-review track.

## 4. Candidate Final Status

Candidate: `Local Clinician-Facing Synthetic Review Demo`

Final status:

- concept defined
- purpose defined
- synthetic-only boundary defined
- local-only boundary defined
- terminal-first boundary defined
- candidate identity requirements defined
- not packaged
- not installed
- not deployed
- not executed
- not runtime-verified
- not machine-approved
- not production-approved
- not clinically approved
- not real-data-approved
- not UI-enabled
- not network-enabled
- not integrated
- not persistent
- not exporting
- not patient-facing
- not approved for go-live

`Candidate definition is not candidate authorization.`

`Authorization packet definition is not execution authorization.`

`Module closure is not production approval.`

## 5. Final Authorization Matrix

| Capability | Definition status | Implementation status | Verification status | Authorization status | Hold status | Required future explicit action |
| --- | --- | --- | --- | --- | --- | --- |
| Documentation completeness | COMPLETE AS DOCUMENTATION | NOT IMPLEMENTED | NOT TESTED | DOCUMENTED ONLY | ON HOLD | New explicit track for any operational work |
| Candidate concept | DEFINED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Candidate execution authorization |
| Candidate identity requirements | DEFINED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Fixed release identity review |
| Machine security requirements | DEFINED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Machine evidence track |
| Machine security implementation | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Security implementation authorization |
| Access control requirements | DEFINED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Access-control track |
| Access control implementation | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Security implementation authorization |
| Custody requirements | DEFINED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Custody evidence track |
| Custody implementation | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Custody authorization |
| Packaging | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Packaging authorization |
| Installation | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Installation authorization |
| Local execution | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Execution-review track |
| Runtime verification | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Runtime verification track |
| No-network design expectation | DEFINED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | No-network verification track |
| No-network verification | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Runtime verification track |
| Listening-port verification | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Runtime verification track |
| Outbound-connection verification | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Runtime verification track |
| External API access | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | New explicit integration track |
| Database access | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | New explicit data track |
| EHR or EMR access | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Real-data governance track |
| Appointment-system access | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Integration governance track |
| Patient-messaging access | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Messaging governance track |
| Telemetry | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Telemetry authorization |
| Analytics | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Analytics authorization |
| Persistence | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Persistence governance track |
| Persistence verification | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Runtime verification track |
| Export | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Export governance track |
| Export verification | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | BLOCKED | Runtime verification track |
| Local logs | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Logging governance track |
| Cache | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Persistence governance track |
| Session history | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Runtime artifact review |
| Browser storage | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | UI/storage authorization |
| UI | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | UI Review Track |
| Real-data read-only | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Real-data governance track |
| PHI | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | PHI governance track |
| PII | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | PII governance track |
| Patient messaging | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Messaging governance track |
| Appointment mutation | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Appointment governance track |
| Clinical writeback | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Clinical workflow track |
| Clinical task creation | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Clinical workflow track |
| Workflow enforcement | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Clinical workflow track |
| Approval or override | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | PROHIBITED | ON HOLD | Governance track |
| Diagnosis | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Clinical safety track |
| Treatment recommendation | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Clinical safety track |
| Triage | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Clinical safety track |
| Patient instruction | DOCUMENTED | NOT IMPLEMENTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Clinical safety track |
| Deployment | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Deployment governance track |
| Production use | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Production governance track |
| Clinical use | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Clinical governance track |
| Go-live | DOCUMENTED | NOT STARTED | NOT TESTED | NOT AUTHORIZED | ON HOLD | Go-live governance track |

## 6. Evidence Status

Evidence exists only for documentation creation, governance definitions, boundary definitions, prerequisite definitions, candidate identity requirements, authorization packet structure, hold records, reopening rules, decision-state definitions, stop-condition definitions, and deviation-handling definitions.

Evidence does not exist for local execution, local installation, machine hardening, machine approval, runtime behavior, no-network behavior, listening-port absence, outbound-connection absence, database-access absence, integration absence, telemetry absence, persistence absence, export absence, runtime safety, clinical validity, production suitability, deployment readiness, operational support, or go-live readiness.

Principles:

- documentation is evidence of documentation
- documentation is not evidence of runtime conformance
- declarations are not verification
- planned controls are not implemented controls
- expected behavior is not observed behavior
- absence of testing is not evidence of safety
- silence is not evidence
- assumption is not evidence
- completion of a template is not approval

## 7. Final Unresolved Blockers

Machine blockers: no identified approved machine, no machine-security evidence, no operating-system review, no update-state evidence, no encryption evidence, no least-privilege evidence, no physical-access evidence, no screen-lock evidence, and no decommission evidence.

Access blockers: no access-control implementation, no authenticated evaluator access record, no privilege boundary verification, no generic-account review, and no revocation implementation.

Custody blockers: no local-copy custody implementation, no fixed release artifact, no acquisition record, no removal record, no version-drift evidence, and no custody-chain evidence.

Runtime blockers: no packaging, no installation, no execution, no runtime verification, no process inspection, no termination verification, and no cleanup verification.

Network blockers: no no-network test, no offline-start test, no listening-port inspection, no outbound-connection inspection, no API-call inspection, no database-access inspection, no telemetry inspection, and no background-service inspection.

Persistence blockers: no file-write inspection, no log inspection, no cache inspection, no history inspection, no browser-storage inspection, no temporary-artifact inspection, and no operating-system artifact assessment.

Export blockers: no export-path inspection, no screenshot-handling validation, no print-path validation, no clipboard-handling validation, and no synchronization review.

UI blockers: No-UI Hold active, no UI purpose approval, no screen inventory, no terminal insufficiency approval, no UI safety-label implementation, and no UI authorization.

Real-data blockers: no legal basis, no privacy review, no data-minimization implementation, no PHI or PII policy implementation, no source-system authorization, no audit implementation, no retention model, no deletion model, and no incident-response activation.

Clinical blockers: no clinical safety validation, no clinician accountability implementation, no patient communication policy activation, no appointment mutation policy activation, no clinical writeback policy activation, no workflow enforcement authorization, no diagnosis authorization, no treatment recommendation authorization, no triage authorization, and no patient instruction authorization.

Deployment blockers: no deployment model, no installer, no package, no environment rollout, no support model, no rollback implementation, no incident-response implementation, no production validation, and no go-live governance.

None of these blockers is resolved by module closure.

## 8. Preserved Holds

### No-UI Hold

Status: `ACTIVE`

UI is not started. No browser surface, local web app, server, API, hosted preview, or UI control implementation exists.

### Synthetic-Only Hold

Status: `ACTIVE`

Repository-controlled synthetic scenarios remain the only permitted content. Real patient-derived content, PHI, and PII are prohibited.

### No-Network Hold

Status: `ACTIVE`

Internet, LAN dependency, cloud, API, database, integration, telemetry, analytics, and remote authentication remain prohibited unless a new explicit track changes the boundary.

### No-Persistence Hold

Status: `ACTIVE`

Saved state, local database, session history, durable logs, browser storage, and hidden history claims remain prohibited or not authorized.

### No-Export Hold

Status: `ACTIVE`

File export, report export, PDF, CSV, spreadsheet, print workflow, screenshot workflow, and synchronization remain prohibited or not authorized.

### No-Integration Hold

Status: `ACTIVE`

External integrations, EHR/EMR, appointment systems, patient messaging systems, databases, and external APIs remain prohibited.

### No-Real-Data Hold

Status: `ACTIVE`

Real-data access, inspection, processing, storage, or transmission remains prohibited.

### No-PHI Hold

Status: `ACTIVE`

PHI handling remains prohibited.

### No-PII Hold

Status: `ACTIVE`

PII handling remains prohibited.

### No-Clinical-Workflow Hold

Status: `ACTIVE`

Patient messaging, appointment mutation, clinical writeback, clinical task creation, workflow enforcement, approval or override, diagnosis, treatment recommendation, triage, patient instruction, and clinical decision execution remain prohibited or not authorized.

### No-Deployment Hold

Status: `ACTIVE`

Package, installer, deployment script, deployment automation, environment rollout, and production deployment remain not started.

### No-Production-Use Hold

Status: `ACTIVE`

Production use, operational use, staff workflow dependence, and clinical-use authorization remain not authorized.

### No-Go-Live Hold

Status: `ACTIVE`

Go-live authorization, production approval, clinical approval, and operational activation remain not authorized.

## 9. Final Closure Decision

`Program 1 Local Production Readiness Track is closed at the documentation and governance level.`

`No execution, evaluation, implementation, machine approval, UI, real-data access, persistence, export, integration, deployment, production use, clinical use, or go-live authorization is granted by this closure.`

`The default repository posture is STOP AND HOLD.`

`No Phase I or execution-review track is opened.`

## 10. Reopening Rules

The module may be reopened only by a new explicit authorization.

Any reopening authorization must name exactly one track, state exact purpose, state exact allowed files, state exact prohibited files, state exact allowed change types, state exact prohibited capabilities, identify required roles, identify decision owner, identify stop authority, define entry criteria, define evidence requirements, define stop conditions, define expiration, define revocation rules, preserve all unrelated holds, and avoid implied approval of downstream work.

Possible future tracks may be listed only as non-authorized examples: documentation-only execution-review design, machine-evidence collection track, no-network runtime verification track, controlled synthetic local execution track, UI review track, real-data governance track, and clinical safety governance track.

None is opened, preferred, planned, authorized, or implied by this closure.

## 11. Supersession Rule

This final closure supersedes prior recommended next step language only with respect to default continuation.

It does not invalidate Phase A boundaries, Phase B machine and access prerequisites, Phase C no-network boundaries, Phase D No-UI Hold, Phase E real-data prerequisites, Phase F hold decisions, Phase G preflight requirements, or Phase H authorization packet requirements. All restrictive boundaries remain active.

## 12. Final Hold Record

Hold name: `Program 1 Local Production Readiness Track Final Deferred Execution Hold`

Hold state:

- module documentation complete
- module governance definition complete
- Phase A complete
- Phase B-F complete
- Phase G complete
- Phase H complete
- candidate concept defined
- candidate execution not authorized
- runtime verification not started
- local evaluation not performed
- machine configuration not started
- machine approval not granted
- packaging not started
- installation not started
- deployment not started
- UI track not started
- real-data track not started
- clinical workflow track not started
- execution-review track not started
- Phase I not started
- No-UI Hold active
- synthetic-only boundary active
- no-network boundary active
- no-persistence boundary active
- no-export boundary active
- no-integration boundary active
- no-clinical-workflow boundary active
- no-production-use boundary active
- no-clinical-use boundary active
- no-go-live boundary active
- final posture `STOP AND HOLD`

Recommended final decision:

`Close the module and take no further action unless a new narrowly scoped track is explicitly authorized.`
